Record 062 · Health · 2020
50%20.62.H
Pfizer–BioNTech COVID-19 Vaccine (Comirnaty)
Pfizer / BioNTech
“A 10-month shot that validated mRNA as a platform and bent a pandemic curve.”
95% efficacy in Phase 3. Emergency use Dec 2020. Billions of doses with Moderna's Spikevax. Platform now being pointed at cancer and flu.
Billions of doses globally across mRNA COVID vaccines
- Modified-nucleoside mRNA + LNP
- Compressed clinical + manufacturing wartime scale
The first authorized mRNA vaccine for a pandemic.
